As the U.S. Judicial Panel on Multidistrict Litigation gears up to hear oral arguments on a motion to establish a multi-district litigation that would centralize nearly 60 cases against manufacturers of dangerous antibiotics, even more lawsuits continue to be filed. The July 30, 2015 hearing was held on behalf of plaintiffs who allege that...
Manufacturers of fluoroquinolone drugs Levaquin, Cipro and Avelox are facing lawsuits from patients harmed by taking these products.
Manufacturers of fluoroquinolone drugs Levaquin, Cipro and Avelox—strong prescription antibiotics that have been linked to permanent nerve damage—who are facing mounting lawsuits throughout the federal court system are opposing plaintiffs’ motions to centralize proceedings. Plaintiffs of the two dozen cases pending in several U.S. District Courts across the country called for consolidation of their cases...Read more
When Dorothy D’Amato developed a lung infection in 2010, she was prescribed Avelox, a strong antibiotic, to treat her condition. After she began experiencing numbness, tingling, and pain in her feet—telltale signs of peripheral neuropathy—D’Amato started getting concerned. Her concern grew to anger, as the fine print that Bayer Healthcare’s drug carried “wasn’t anywhere...Read more
While recovering from knee surgery, Judy Shurman took only three doses of the antibiotic Levaquin before she started feeling completely paranoid. “I locked the bedroom door. I wouldn’t let anybody in. At some point I was beside the bed hiding on the floor,” she said. The popular antibiotic carries the FDA’s “black box” warning, recommending...Read more